Spyridon Gkalpakiotis (S Gkalpakiotis)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 25

Top Venues

Dermatology and therapy

Dermatologic therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

The Journal of dermatological treatment

Charles university

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charles university

Czechia

Assistant professor :: Third faculty of medicine,Dermatovenereology

Publications

Spyridon Gkalpakiotis, Susanna M H Kannenberg, Külli Kingo, Hanan Rabea Nada, Margarita R Rakhmatulina, Aleksandra Lesiak, Alin Codrut Nicolescu, Razvigor Darlenski, Alaa Masri, Limei Zhou, Teotonio Albuquerque, Shereen Hammad, Iman Almasry
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study. Dermatology and therapy 14 (5) (2024)
Spyridon Gkalpakiotis, Susanna M H Kannenberg, Külli Kingo, Hanan Rabea Nada, Margarita R Rakhmatulina, Aleksandra Lesiak, Alin Codrut Nicolescu, Razvigor Darlenski, Alaa Masri, Limei Zhou, Teotonio Albuquerque, Shereen Hammad, Iman Almasry
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study. Dermatology and therapy 14 (5) (2024)
Spyridon Gkalpakiotis, Susanna M H Kannenberg, Külli Kingo, Hanan Rabea Nada, Margarita R Rakhmatulina, Aleksandra Lesiak, Alin Codrut Nicolescu, Razvigor Darlenski, Alaa Masri, Limei Zhou, Teotonio Albuquerque, Shereen Hammad, Iman Almasry
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study. Dermatology and therapy 14 (5) (2024)
Andrea Chiricozzi, Giulia Coscarella, Lluis L Puig, Ronald B Vender, Jensen Yeung, Y José Manuel Carrascosa, Stefano Piaserico, Paolo Gisondi, Charles Lynde, Paulo Ferreira, Pedro Mendes Bastos, Esteban Daudén, Luiz Leite, Joana Valerio, Elena Del Alcázar-Viladomiu, Eva Vilarrasa, Mar Llamas Velasco, Mario Alessandri-Bonetti, Francesco Messina, Manfredo Bruni, Eugenia Veronica Di Brizzi, Federica Ricceri, Alessia Nidegger, Jan Hugo, Asfandyar Mufti, Athina-Ioanna Daponte, Laetitia Teixeira, Anna Balato, Marco Romanelli, Francesca Prignano, Spyridon Gkalpakiotis, Curdin Conrad, Elizabeth Lazaridou, Natalia Rompoti, Alexander J Stratigos, Miguel Nogueira, Ketty Peris, Tiago Torres
Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Spyridon Gkalpakiotis, Susanna M H Kannenberg, Külli Kingo, Hanan Rabea Nada, Margarita R Rakhmatulina, Aleksandra Lesiak, Alin Codrut Nicolescu, Razvigor Darlenski, Alaa Masri, Limei Zhou, Teotonio Albuquerque, Shereen Hammad, Iman Almasry
Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis: Results From the ESSENTIAL AD Multicountry Study. Dermatology and therapy (2024)
Spyridon Gkalpakiotis, Martina Kojanová, Jorga Fialová, Petra Cetkovská, Vladimír Vašků, Yvetta Vantuchová, Alena Machovcová, Petra Gkalpakioti, Pavla Hrdá, Petr Arenberger
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic. Dermatology and therapy (2023)
Martina Kojanova, Milena Tanczosova, Daniela Strosova, Petra Cetkovska, Jorga Fialova, Tomas Dolezal, Alena Machovcova, Spyridon Gkalpakiotis, null null
Dupilumab for the treatment of atopic dermatitis: real-world data from the Czech Republic BIOREP registry. The Journal of dermatological treatment 33 (5) (2022)
Martin Tichy, Martina Kojanova, Barbora Velackova, Tomas Dolezal, Spyridon Gkalpakiotis, Petra Cetkovska, null null
Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP). Dermatologic therapy 35 (10) (2022)
Spyridon Gkalpakiotis, Marketa Fridman, Simona Tivadar
Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab. Dermatology and therapy 12 (2) (2022)
Martina Kojanova, Jan Hugo, Barbora Velackova, Petra Cetkovska, Jorga Fialova, Tomas Dolezal, Martin Tichy, Spyridon Gkalpakiotis, null null
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry. The Journal of dermatological treatment 33 (6) (2022)
Petr Šíma, Valér Džupa, Adam Whitley, Spyridon Gkalpakiotis
Leg Ulcer Therapy by Local Injection of Autologous Growth Factors: Results of a Pilot Study. Dermatology and therapy 12 (7) (2022)
Spyridon Gkalpakiotis, Tereza Maresova
Severe atopic dermatitis in a patient with Loeys-Dietz syndrome treated with dupilumab. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Monika Arenbergerova, Spyridon Gkalpakiotis, Emanuel Marques, P Arenberger, R A Dahmen, A Smetanova
Corticosteroid rescue therapy in relapsing hidradenitis suppurativa treated with adalimumab. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (6) (2021)
Milena Tanczosova, Petr Arenberger, Ivan Rychlik, Monika Arenbergerova, Spyridon Gkalpakiotis
Improvement of atopic dermatitis and IgA nephropathy in a patient treated by dupilumab. Dermatologic therapy 34 (1) (2021)
Athanasios J Stefanis, Petr Arenberger, Monika Arenbergerova, Spyridon Gkalpakiotis
Alopecia barbae severity score: a novel scoring system to estimate the extent of beard loss and success of treatment. The British journal of dermatology 185 (4) (2021)
Martina Kojanova, Petra Cetkovska, Daniela Strosova, Jorga Fialova, Petr Arenberger, Tomas Dolezal, Spyridon Gkalpakiotis, null null
Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic. Dermatology and therapy 11 (2) (2021)
Spyridon Gkalpakiotis, Petra Cetkovska, Petr Arenberger, Tomas Dolezal, Monika Arenbergerova, Barbora Velackova, Jorga Fialova, Martina Kojanova, null null
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic. Dermatology and therapy 11 (4) (2021)
Martina Kojanova, Jorga Fialova, Petra Cetkovska, Thomas Dolezal, Iva Lomicova, Petr Arenberger, Spyridon Gkalpakiotis, null null
Demographic data, comorbidities, quality of life, and survival probability of biologic therapy associated with sex-specific differences in psoriasis in the Czech Republic. Dermatologic therapy 34 (2) (2021)
Spyridon Gkalpakiotis, Monika Arenbergerova, Petra Gkalpakioti, Jana Potockova, Petr Arenberger, Pavel Kraml
Long-term impact of adalimumab therapy on biomarkers of systemic inflammation in psoriasis: Results of a 2 year study. Dermatologic therapy 33 (6) (2020)
M Arenbergerova, Spyridon Gkalpakiotis, P Arenberger, A Fialova, M Pasek
COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma. The Journal of dermatological treatment (2020)
Spyridon Gkalpakiotis, Petr Arenberger, P Skalicka, M Arenbergerova
Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (6) (2020)
Athanasios J Stefanis, Klara Labska, Eva Sticova, Monika Arenbergerova, Petr Arenberger, Robert Zajicek, Spyridon Gkalpakiotis
Darier disease complicated by severe Kaposi varicelliform eruption resistant to acyclovir. Dermatologic therapy 33 (6) (2020)
Monika Arenbergerova, Alena Fialova, Petr Arenberger, Spyridon Gkalpakiotis, Marek Pasek, Martina Putzova
Targeted treatment of metastatic melanoma in a drug-addicted patient with pre-existing hepatitis C. Dermatologic therapy 32 (2) (2018)
Elizabeth Adenubiova, Petr Arenberger, Petra Gkalpakioti, Monika Arenbergerova, Jitka Jircikova, Tomas Dolezal, Spyridon Gkalpakiotis
Psoriasis treatment with adalimumab in clinical practice: long-term experience in a center for biological therapy in the Czech Republic. The Journal of dermatological treatment 29 (6) (2018)
Spyridon Gkalpakiotis, Petr Arenberger, Marketa Fridman, Monika Arenbergerova
Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma. Dermatologic therapy 30 (6) (2017)

Spyridon Gkalpakiotis.css-eqlu8i{font-size:small;padding-left:4px;} (S Gkalpakiotis)

Publication Activity (10 Years)

Top Topics

Top Venues

Spyridon Gkalpakiotis (S Gkalpakiotis)